| Nome |
# |
|
Cryoglobulinaemia, file e27ce42d-a6cc-2581-e053-d805fe0acbaa
|
1.452
|
|
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, file e27ce42d-c60a-2581-e053-d805fe0acbaa
|
1.320
|
|
Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature, file e27ce429-e44b-2581-e053-d805fe0acbaa
|
1.244
|
|
Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome, file e27ce429-fbfa-2581-e053-d805fe0acbaa
|
1.244
|
|
Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review, file e27ce42b-89b5-2581-e053-d805fe0acbaa
|
1.180
|
|
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment, file e27ce429-f574-2581-e053-d805fe0acbaa
|
1.089
|
|
Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus: a systematic review., file e27ce427-03f0-2581-e053-d805fe0acbaa
|
1.007
|
|
Renal involvement in antiphospholipid syndrome., file e27ce429-e19d-2581-e053-d805fe0acbaa
|
975
|
|
Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review., file e27ce42a-2a0b-2581-e053-d805fe0acbaa
|
926
|
|
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances, file e27ce42d-eec5-2581-e053-d805fe0acbaa
|
880
|
|
IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine., file e27ce426-ce28-2581-e053-d805fe0acbaa
|
801
|
|
GAPSS: the Global Anti-Phospholipid Syndrome Score., file e27ce42a-6cb8-2581-e053-d805fe0acbaa
|
785
|
|
Antiphospholipid syndrome and relapsing polychondritis: an unusual association., file e27ce426-d1c0-2581-e053-d805fe0acbaa
|
775
|
|
Acute renal infarction: a single center experience, file e27ce429-f651-2581-e053-d805fe0acbaa
|
695
|
|
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients., file e27ce426-d1b3-2581-e053-d805fe0acbaa
|
639
|
|
Catastrophic antiphospholipid syndrome (CAPS)., file e27ce426-fd6d-2581-e053-d805fe0acbaa
|
602
|
|
Systemic lupus erythematosus and infections: clinical importance of conventional and upcoming biomarkers., file e27ce426-fc64-2581-e053-d805fe0acbaa
|
600
|
|
Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature., file e27ce426-d392-2581-e053-d805fe0acbaa
|
568
|
|
Chiari and Syringomyelia Consortium: a model of multidisciplinary and sharing path for rare diseases., file e27ce426-d393-2581-e053-d805fe0acbaa
|
568
|
|
IgG4-related nephropathy, file e27ce429-ef65-2581-e053-d805fe0acbaa
|
559
|
|
Dealing with stuck hemodialysis catheter: state of the art and tips for the nephrologist., file e27ce42a-0811-2581-e053-d805fe0acbaa
|
538
|
|
Infliximab Biosimilars in the Treatment of Inflammatory Bowel Diseases: A Systematic Review, file e27ce42b-d333-2581-e053-d805fe0acbaa
|
527
|
|
Acute kidney injury associated with glomerular diseases, file e27ce42e-d0b3-2581-e053-d805fe0acbaa
|
517
|
|
Antiphospholipid Syndrome and the Kidney, file e27ce429-fc69-2581-e053-d805fe0acbaa
|
507
|
|
Common variable immunodeficiency: Crossroads between infections, inflammation and autoimmunity., file e27ce42a-51ac-2581-e053-d805fe0acbaa
|
505
|
|
Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases., file e27ce426-e13d-2581-e053-d805fe0acbaa
|
493
|
|
Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence, file e27ce42b-a1cf-2581-e053-d805fe0acbaa
|
487
|
|
Rituximab in cryoglobulinemic peripheral neuropathy, file e27ce426-d1b1-2581-e053-d805fe0acbaa
|
484
|
|
Autologous hematopoietic stem cell transplantation in Systemic Lupus Erythematosus and antiphospholipid syndrome: A systematic review, file e27ce42b-648e-2581-e053-d805fe0acbaa
|
484
|
|
The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment, file e27ce42d-ebe9-2581-e053-d805fe0acbaa
|
474
|
|
Novel diagnostic and therapeutic frontiers in thrombotic anti-phospholipid syndrome, file e27ce42b-8f7d-2581-e053-d805fe0acbaa
|
433
|
|
The risk of ischaemic stroke in primary APS patients: a prospective study, file e27ce42d-8fd1-2581-e053-d805fe0acbaa
|
431
|
|
Improved (4 Plus 2) rituximab protocol for severe cases of mixed cryoglobulinemia: A 6-year observational study, file e27ce429-fab1-2581-e053-d805fe0acbaa
|
429
|
|
Radiotherapy in patients with connective tissue diseases, file e27ce429-fc2d-2581-e053-d805fe0acbaa
|
423
|
|
Rheumatoid arthritis: Biological therapy other than anti-TNF, file e27ce42a-04ae-2581-e053-d805fe0acbaa
|
417
|
|
The role of nail-videocapillaroscopy in early diagnosis of scleroderma, file e27ce429-e1da-2581-e053-d805fe0acbaa
|
415
|
|
Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases., file e27ce429-e8da-2581-e053-d805fe0acbaa
|
413
|
|
[Extracorporeal therapy in sepsis], file e27ce42e-6cce-2581-e053-d805fe0acbaa
|
405
|
|
Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphospholipid syndrome: A multicenter study, file e27ce42e-ad43-2581-e053-d805fe0acbaa
|
403
|
|
Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression., file e27ce426-d1bd-2581-e053-d805fe0acbaa
|
401
|
|
Prevalence and Thrombotic Risk Assessment of Anti-beta(2) Glycoprotein I Domain I Antibodies: A Systematic Review, file e27ce42d-ede1-2581-e053-d805fe0acbaa
|
389
|
|
Pregnancy outcomes in mixed connective tissue disease: a multicentre study, file e27ce42e-e06c-2581-e053-d805fe0acbaa
|
387
|
|
Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis., file e27ce42a-2f4c-2581-e053-d805fe0acbaa
|
382
|
|
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction, file e27ce42b-a1cb-2581-e053-d805fe0acbaa
|
378
|
|
Systemic AA amyloidosis as a unique manifestation of a combined mutation of TNFRSF1A and MEFV genes., file e27ce42a-324e-2581-e053-d805fe0acbaa
|
373
|
|
The global anti-phospholipid syndrome score in primary APS., file e27ce42a-3766-2581-e053-d805fe0acbaa
|
367
|
|
Rate of Adverse Effects of Medium- to High-Dose Glucocorticoid Therapy in Systemic Lupus Erythematosus: A Systematic Review of Randomized Control Trials, file e27ce42b-a1d5-2581-e053-d805fe0acbaa
|
354
|
|
Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: an achievable target?, file e27ce429-e7c8-2581-e053-d805fe0acbaa
|
353
|
|
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies, file e27ce42d-cdeb-2581-e053-d805fe0acbaa
|
353
|
|
Venous Window Needle Guide for deep vessels and difficult arteriovenous fistula cannulation, file e27ce429-f50f-2581-e053-d805fe0acbaa
|
349
|
|
A randomized, controlled, trial of rituximab for treatment of severe cryoglobulinemic vasculitis., file e27ce426-d396-2581-e053-d805fe0acbaa
|
322
|
|
Upcoming biological therapies in systemic lupus erythematosus., file e27ce429-f5de-2581-e053-d805fe0acbaa
|
301
|
|
Nemo syndrome (incontinentia pigmenti) and systemic lupus erythematosus: a new disease association., file e27ce426-d2ff-2581-e053-d805fe0acbaa
|
298
|
|
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study, file e27ce429-f908-2581-e053-d805fe0acbaa
|
290
|
|
Thrombotic recurrences and bleeding events in APS vascular patients: a review from the literature and a comparison with the APS Piedmont Cohort., file e27ce426-fd68-2581-e053-d805fe0acbaa
|
277
|
|
Living With and Treating Rare Diseases: Experiences of Patients and Professional Health Care Providers, file e27ce42a-0730-2581-e053-d805fe0acbaa
|
277
|
|
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents, file e27ce42d-9fdb-2581-e053-d805fe0acbaa
|
274
|
|
Novel diagnostic approaches and cost-benefit balance of treatment of immune-mediated and rare disease in the era of biologic drugs: lessons from the 15th Turin Congress on Immune Pathology and Orphan Disease., file e27ce426-fd69-2581-e053-d805fe0acbaa
|
272
|
|
Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein), file e27ce42d-a373-2581-e053-d805fe0acbaa
|
263
|
|
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy, file e27ce426-d1b4-2581-e053-d805fe0acbaa
|
254
|
|
The dilemma of treating hepatitis C virus-associated cryoglobulinemia, file e27ce42e-f78d-2581-e053-d805fe0acbaa
|
254
|
|
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study, file e27ce42d-ae45-2581-e053-d805fe0acbaa
|
251
|
|
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors, file e27ce42e-eef7-2581-e053-d805fe0acbaa
|
251
|
|
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement, file e27ce42d-a8f5-2581-e053-d805fe0acbaa
|
249
|
|
Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection, file e27ce42a-080f-2581-e053-d805fe0acbaa
|
248
|
|
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning., file e27ce429-ecd3-2581-e053-d805fe0acbaa
|
246
|
|
Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS, file e27ce42e-d865-2581-e053-d805fe0acbaa
|
246
|
|
Independent validation of the antiphospholipid score for the diagnosis of antiphospholipid syndrome., file e27ce42a-01a2-2581-e053-d805fe0acbaa
|
237
|
|
Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab, file e27ce42d-a247-2581-e053-d805fe0acbaa
|
227
|
|
"How I treat" autoimmune diseases: State of the art on the management of rare rheumatic diseases and ANCA-associated systemic idiopathic vasculitis, file e27ce42d-a342-2581-e053-d805fe0acbaa
|
227
|
|
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring, file e27ce42e-d349-2581-e053-d805fe0acbaa
|
225
|
|
A victim of the Occam's razor., file e27ce426-fd66-2581-e053-d805fe0acbaa
|
222
|
|
How I treat patients with systemic sclerosis in clinical practice, file e27ce42d-c187-2581-e053-d805fe0acbaa
|
222
|
|
Treatment-induced downregulation of antiphospholipid antibodies: effect of rituximab alone on clinical and laboratory features of antiphospholipid syndrome., file e27ce426-d1b6-2581-e053-d805fe0acbaa
|
221
|
|
Development of a Shared Clinical Pathway for Taking Charge of Patients with Hereditary and Acquired C1 Estherase Inhibitor Deficiency Angioedema, file 5c1900da-b8c6-489f-ae2b-5c5d2a556879
|
220
|
|
Pregnancy success rate and response to heparins and/or aspirin differ in women with antiphospholipid antibodies according to their Global AntiphosPholipid Syndrome Score, file e27ce430-70db-2581-e053-d805fe0acbaa
|
206
|
|
Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile., file e27ce426-d61a-2581-e053-d805fe0acbaa
|
198
|
|
Factor IX propeptide mutation and life threatening bleeding, file e27ce426-d22a-2581-e053-d805fe0acbaa
|
194
|
|
Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities., file e27ce42a-35b0-2581-e053-d805fe0acbaa
|
193
|
|
The case of SLE associated Sneddon-Wilkinson pustular disease successfully and safely treated with infliximab, file e27ce426-b60b-2581-e053-d805fe0acbaa
|
192
|
|
Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria., file e27ce42a-09c3-2581-e053-d805fe0acbaa
|
190
|
|
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome, file e27ce430-41be-2581-e053-d805fe0acbaa
|
189
|
|
Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C, file e27ce427-3066-2581-e053-d805fe0acbaa
|
170
|
|
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis, file e27ce42f-8cad-2581-e053-d805fe0acbaa
|
167
|
|
A multidrug, antiproteinuric approach to alport syndrome: a ten-year cohort study, file e27ce427-2fe7-2581-e053-d805fe0acbaa
|
160
|
|
Filling the gap in antiphospholipid syndrome diagnosis: a patient's story, file e27ce42f-98df-2581-e053-d805fe0acbaa
|
160
|
|
Antiphospholipid antibodies: crossroads between autoimmunity and infections?, file e27ce42b-7a39-2581-e053-d805fe0acbaa
|
158
|
|
Thrombotic risk assessment in antiphospholipid syndrome: The role of new antibody specificities and thrombin generation assay, file e27ce429-e533-2581-e053-d805fe0acbaa
|
156
|
|
Thrombotic risk assessment in systemic lupus erythematosus: validation of the global antiphospholipid syndrome score in a prospective cohort., file e27ce427-03ef-2581-e053-d805fe0acbaa
|
154
|
|
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9), file e27ce433-fc20-2581-e053-d805fe0acbaa
|
145
|
|
Migraineurs show a high prevalence of antiphospholipid antibodies., file e27ce426-d1b5-2581-e053-d805fe0acbaa
|
144
|
|
Biallelic variants in the ciliary gene TMEM67 cause RHYNS syndrome, file e27ce42d-ec84-2581-e053-d805fe0acbaa
|
143
|
|
Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment, file e27ce427-3068-2581-e053-d805fe0acbaa
|
138
|
|
The Case | the young philosopher with multiple sclerosis and proteinuria, file e27ce429-c85d-2581-e053-d805fe0acbaa
|
125
|
|
Clinical utility of the global anti-phospholipid syndrome score for risk stratification: A pooled analysis, file e27ce42d-a36c-2581-e053-d805fe0acbaa
|
122
|
|
Outpatient percutaneous native renal biopsy: Safety profile in a large monocentric cohort, file e27ce42d-cba9-2581-e053-d805fe0acbaa
|
122
|
|
The potential role of SLE-key test in identifying patients with Systemic Lupus Erythematosus: Results from a prospective, real-world experience, file e27ce42e-cbae-2581-e053-d805fe0acbaa
|
122
|
|
IgG4-related kidney disease: The effects of a Rituximab-based immunosuppressive therapy, file e27ce42d-a4c4-2581-e053-d805fe0acbaa
|
118
|
|
Recent advances in the management of systemic lupus erythematosus, file e27ce42d-9afd-2581-e053-d805fe0acbaa
|
117
|
|
Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome, file e27ce42d-ac56-2581-e053-d805fe0acbaa
|
117
|
| Totale |
41.054 |